Host-targeting oral antiviral drugs to prevent pandemics

被引：13
|
作者：
Dwek, Raymond A. [1 ]
Bell, John I. [2 ]
Feldmann, Marc [3 ,4 ]
Zitzmann, Nicole [1 ]
机构：
[1] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England
[2] Univ Oxford, Div Med Sci, Oxford OX1 3QU, England
[3] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX1 3QU, England
[4] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford OX1 3QU, England
来源：
LANCET | 2022年 / 399卷 / 10333期
关键词：
N-BUTYLDEOXYNOJIRIMYCIN; GLYCOSYLATION; COMBINATION; INFECTION; VIRUS;
D O I：
10.1016/S0140-6736(22)00454-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1381 / 1382
页数：2
相关论文
共 50 条
  • [41] Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly
    Reed, Jonathan C.
    Solas, Dennis
    Kitaygorodskyy, Anatoliy
    Freeman, Beverly
    Ressler, Dylan T. B.
    Phuong, Daryl J.
    Swain, J. Victor
    Matlack, Kent
    Hurt, Clarence R.
    Lingappa, Vishwanath R.
    Lingappa, Jaisri R.
    JOURNAL OF VIROLOGY, 2021, 95 (03)
  • [42] SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals
    Nils C. Gassen
    Jan Papies
    Thomas Bajaj
    Jackson Emanuel
    Frederik Dethloff
    Robert Lorenz Chua
    Jakob Trimpert
    Nicolas Heinemann
    Christine Niemeyer
    Friderike Weege
    Katja Hönzke
    Tom Aschman
    Daniel E. Heinz
    Katja Weckmann
    Tim Ebert
    Andreas Zellner
    Martina Lennarz
    Emanuel Wyler
    Simon Schroeder
    Anja Richter
    Daniela Niemeyer
    Karen Hoffmann
    Thomas F. Meyer
    Frank L. Heppner
    Victor M. Corman
    Markus Landthaler
    Andreas C. Hocke
    Markus Morkel
    Nikolaus Osterrieder
    Christian Conrad
    Roland Eils
    Helena Radbruch
    Patrick Giavalisco
    Christian Drosten
    Marcel A. Müller
    Nature Communications, 12
  • [43] TARGETING OF ANTIVIRAL DRUGS TO THE LIVER USING GLYCOPROTEIN CARRIERS
    FIUME, L
    BUSI, C
    DISTEFANO, G
    MATTIOLI, A
    ADVANCED DRUG DELIVERY REVIEWS, 1994, 14 (01) : 51 - 65
  • [44] Development of antiviral drugs targeting the flaviviruses fusion mechanism
    Kampmann, T
    Yennamalli, R
    Stöermer, M
    Kobe, B
    Young, P
    FEBS JOURNAL, 2005, 272 : 553 - 553
  • [45] A Novel Approach of Antiviral Drugs Targeting Viral Genomes
    Phuong Thi Hoang
    Quynh Xuan Thi Luong
    Ayun, Ramadhani Qurrota
    Lee, Yongjun
    Thuy Thi Bich Vo
    Kim, Taehyun
    Lee, Sukchan
    MICROORGANISMS, 2022, 10 (08)
  • [46] Antiviral Drugs to Prevent Clinical Recurrence in Patients with Genital Herpes
    Sands-Lincoln, Megan
    Goldmann, David R.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (12): : 1264 - 1266
  • [47] Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemics
    Lue, Zirui
    Dai, Xiandong
    Xu, Jianjie
    Liu, Zhenming
    Guo, Yongbiao
    Gao, Zhenhua
    Meng, Fanhua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 271
  • [48] Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances
    Tammaro, Chiara
    Guida, Michela
    Appetecchia, Federico
    Biava, Mariangela
    Consalvi, Sara
    Poce, Giovanna
    PHARMACEUTICALS, 2023, 16 (02)
  • [49] Oreoch-1: A broad-spectrum virus and host-targeting peptide against animal infections
    Nastri, Bianca M.
    Chianese, Annalisa
    Giugliano, Rosa
    Di Clemente, Laura
    Capasso, Carla
    Monti, Alessandra
    Doti, Nunzianna
    Iovane, Valentina
    Montagnaro, Serena
    Pagnini, Ugo
    Iovane, Giuseppe
    Zannella, Carla
    De Filippis, Anna
    Galdiero, Massimiliano
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30 (07)
  • [50] Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2
    Niemeyer, Brian F.
    Benam, Kambez H.
    PHARMACOLOGY & THERAPEUTICS, 2022, 233
12345